Continuous Blood Glucose Monitoring and Insulin Pumps

DCCT Research Group, 1993, Diabetes Control and Complications Trial (DCCT): The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus, N Eng J Med, 329, 977, 10.1056/NEJM199309303291401 UK prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Diabetes Control and Complications Trial Research Group, 1995, Implementation of treatment protocols in the Diabetes Control and Complications Trial, Diabetes Care, 18, 361, 10.2337/diacare.18.3.361 Boaz-Christy, 1999, Up and Pumping: chart your way to better control, Diabetes Interview, March, 30 Brody JE. Small, conventional and flexible, insulin pumps catch on. New York Times. August 10, 1999; Personal Health Section. Saudek, 1997, Novel forms of insulin delivery, Endocrinol Metab Clin North Am, 26, 599, 10.1016/S0889-8529(05)70269-3 Pickup, 1978, Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia, BMJ, 1, 204, 10.1136/bmj.1.6107.204 Tamborlane, 1979, Normalization of plasma glucose in juvenile diabetics by subcutaneous administration of insulin with a portable infusion pump, N Eng J Med, 300, 573, 10.1056/NEJM197903153001101 Unger, 1979, Meticulous control of diabetes: benefits, risks and precautions, Diabetes, 31, 479, 10.2337/diab.31.6.479 Arias, 1985, Incidence of hypoglycemic episodes inpatients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24 hours continuous blood glucose monitoring, Diabetes Care, 8, 134, 10.2337/diacare.8.2.134 White, 1983, Identification of type 1 diabetic patient at increased risk for hypoglycemia during intensive therapy, N Eng J Med, 308, 485, 10.1056/NEJM198303033080903 Del Rio, 1989, Adrenomedullary hyperactivity in type 1 diabetic patients before and during continuous subcutaneous insulin treatment, J Clin Endocrinol Metab, 68, 555, 10.1210/jcem-68-3-555 Kanc, 1998, Subsituition of night time continuous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycemia in IDDM, Diabetolgia, 41, 322, 10.1007/s001250050910 Feldt-Rasmussen, 1986, Effect of 2 years of strict metabolic control on progression of incipient nephropathy in insulin dependent diabetes, Lancet, 1, 1300, 10.1016/S0140-6736(86)91433-9 Deckert, 1984, Effect of 2 years of strict metabolic control on kidney function in long term insulin dependent diabetes, Diabet Nephropathy, 3, 6 Boulton, 1982, Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy, Diabetes Care, 5, 386, 10.2337/diacare.5.4.386 Jakobsen, 1998, Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type 1 diabetes, Diabetes, 37, 452, 10.2337/diabetes.37.4.452 Helve, 1987, Continuous insulin infusion therapy and retinopathy in patients with type 1 diabetes, Acta Endocrinol (Copenh), 115, 313, 10.1530/acta.0.1150313 Schimtz, 1987, Metabolic control in newly kidney transplanted insulin dependent diabetics: improvement by insulin pump treatment (CSII), J Diabet Complications, 1, 81, 10.1016/S0891-6632(87)80061-2 Marcus AO. Patient selection for insulin pump therapy. Pract Diabetol November 1992: 12-18. Home, 1984, Problems and safety of continuous subcutaneous insulin infusion, Diabet Medicine, 1, 41, 10.1111/j.1464-5491.1984.tb01920.x Mecklenburg, 1986, Malfunction of continuous subcutaneous insulin infusion systems: a one year prospective study of 127 patients, Diabetes Care, 9, 351, 10.2337/diacare.9.4.351 Peden, 1984, Diabetic Ketoacidosis with long term treatment with continuous subcutaneous insulin infusion, Diabetes Care, 7, 1, 10.2337/diacare.7.1.1 Castillo, 1995, Treatment with insulin infusion pumps and ketoacidotic episodes: from physiology to troubleshooting, Diabetes Metab Rev, 11, 161, 10.1002/dmr.5610110206 Pietre, 1981, Cutaneous complications of chronic continuous subcutaneous insulin infusion therapy, Diabetes Care, 17, 1235 Strowig, 1997, Intensive management of insulin-dependent diabetes mellitus, 709 Chantelau, 1987, Acute cutaneous complications and catheter needle colonization during insulin pump treatment, Diabetes Care, 10, 478, 10.2337/diacare.10.4.478 Wickline, 1989, Cellulitis caused by Rhizomucor pusillus in a diabetic patient receiving continuous subcutaneous insulin infusion therapy, Southerm Med J, 82, 1432, 10.1097/00007611-198911000-00024 Van Den Hove, 1996, Allergic contact dermatitis from acrylates in insulin pump infusion sets, Contact Dermatitis, 35, 108, 10.1111/j.1600-0536.1996.tb02305.x Corazza, 1998, Nickel contact dermatitis due to needle of an insulin pump, confirmed by microanalysis, Contact Dermatitis, 39, 144, 10.1111/j.1600-0536.1998.tb05875.x Schmaub, 1998, Human insulin analogue [LYS(B 28), PRO(B29)]: the ideal pump insulin?, Diabet Med, 15, 247, 10.1002/(SICI)1096-9136(199803)15:3<247::AID-DIA547>3.0.CO;2-T Attia, 1998, Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM, Diabetes Care, 21, 817, 10.2337/diacare.21.5.817 Kitzmiller, 1978, Diabetic pregnancy and perinatal morbidity, Am J Obstet Gynecol, 131, 560, 10.1016/0002-9378(78)90120-5 Jensen, 1986, Preconceptional treatment with insulin infusion pumps in insulin dependent diabetic women with particular reference to prevention of congenital malformations, Acta Endocrinol Siuppl (Copenh), 277, 81, 10.1530/acta.0.111S0081 Carta, 1986, Continuous subcutaneous insulin infusion versus intensive insulin therapy in type I and type II diabetic pregnancy, Diabete metab, 12, 121 Jornsay, 1998, Continuous subcutaneous insulin infusion (CSII) therapy during pregnancy, Diabetes Spectrum, 11, 26 Della Casa, 1990, Effect of 6 month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM; role of initial continuous subcutaneous insulin infusion-induced normoglycemia, Am J Med, 90, 37S Moura, 1997, Short term effects of continuous insulin infusion treatment on insulin secretion in non insulin-dependent overweight patients with poor glycemic control despite maximal oral antidiabetic treatment, Diabete Metab, 23, 51 Lormeau, 1997, Hyperinsulinemia and hypofibrinolysis: effects of short term optimized glycemic control with continuous insulin infusion in type II diabetic patients, Metabolosm, 46, 1074, 10.1016/S0026-0495(97)90281-X Schmulling, 1990, Exercise and insulin requirements, Horm Metab Res, 24, 83 Mitchell, 1988, Hyperglycemia after intense exercise in IDDM subjects during continuous insulin infusion, Diabetes Care, 11, 311, 10.2337/diacare.11.4.311 Yki-Jarvinen, 1984, Normalization of insulin sensitivity in type I diabetic subjects by physical training during insulin pump therapy, Diabetes Care, 7, 520, 10.2337/diacare.7.6.520 Thuesen, 1986, Exercise capacity and cardiac function in type 1 diabetic patients treated with continuous subcutaneous insulin infusion: a controlled study, Scan J Clin Lab Invest, 46, 779, 10.3109/00365518609084050